Modulation of hepatic apolipoprotein B, 3-hydroxy-3-methylglutaryl-CoA reductase and low-density lipoprotein receptor mRNA and plasma lipoprotein concentrations by defined dietary fats. Comparison of trimyristin, tripalmitin, tristearin and triolein.
Different dietary fatty acids exert specific effects on plasma lipids but the mechanism by which this occurs is unknown. Hamsters were fed on low-cholesterol diets containing triacylglycerols enriched in specific saturated fatty acids, and effects on plasma lipids and the expression of genes involved in hepatic lipoprotein metabolism were measured. Trimyristin and tripalmitin caused significant rises in low-density lipoprotein (LDL) cholesterol which were accompanied by significant reductions in hepatic LDL receptor mRNA levels. Tripalmitin also increased hepatic expression of the apolipoprotein B gene, implying an increased production of LDL via very-low-density lipoprotein (VLDL) and decreased removal of LDL in animals fed this fat. Hepatic levels of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA did not vary significantly between the groups. Compared with triolein, tristearin had little effect on hepatic gene expression or total plasma cholesterol. However, it caused a marked decrease in VLDL cholesterol and a rise in LDL cholesterol such that overall it appeared to be neutral. Lipid analysis suggested a rapid desaturation of much of the dietary stearate. The differential changes in plasma lipids and hepatic mRNA levels induced by specific dietary fats suggests a role for fatty acids or a metabolite thereof in the regulation of the expression of genes involved in lipoprotein metabolism.
Bennett
A J
AJ
Department of Biochemistry, University of Nottingham Medical School, U.K.
Billett
M A
MA
Salter
A M
AM
Mangiapane
E H
EH
Bruce
J S
JS
Anderton
K L
KL
Marenah
C B
CB
Lawson
N
N
White
D A
DA
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001055:Apolipoproteins B / Q000235:genetics*; D001483:Base Sequence; D002784:Cholesterol / Q000097:blood; D006224:Cricetinae; D004041:Dietary Fats / Q000008:administration & dosage / Q000494:pharmacology*; D005227:Fatty Acids / Q000008:administration & dosage / Q000378:metabolism; D006903:Hydroxymethylglutaryl CoA Reductases / Q000235:genetics*; D008074:Lipoproteins / Q000097:blood*; D008099:Liver / Q000378:metabolism*; D008297:Male; D008647:Mesocricetus; D008969:Molecular Sequence Data; D012333:RNA, Messenger / Q000378:metabolism; D011973:Receptors, LDL / Q000235:genetics*; D014280:Triglycerides / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology
D001055:Apolipoproteins B; D004041:Dietary Fats; D005227:Fatty Acids; D008074:Lipoproteins; D012333:RNA, Messenger; D011973:Receptors, LDL; D014280:Triglycerides; C036694:trimyristin; D002784:Cholesterol; C005859:tripalmitin; D006903:Hydroxymethylglutaryl CoA Reductases